More on LTRN

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (6.7 Score)

Upcoming Events

- Earnings (5/15/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Lantern Pharma (NQ:LTRN)
Delayed: 2.70 -0.03 (1.1%)
Prev. Close $2.73  
Open$2.76 
52 Wk High$ 
52 Wk Low$ 
Day High$2.76 
Day Low$2.65 
P/E N/A  
EPS$ 
Volume16,922 

Friends, Peers and Foes (?): 0N6A, ALTME, CMRX, ACTU ENLV (more...)

Feb 23, 2026 04:37 PM Form SCHEDULE 13D/A Lantern Pharma Inc. Filed by: Bios Equity Partners, LP
Feb 10, 2026 08:45 AM Lantern Pharma to Present at the 7th Glioblastoma Drug Development Summit in Boston on February 17-19, 2026
Jan 23, 2026 07:31 AM Form 8-K Lantern Pharma Inc. For: Jan 22
Jan 20, 2026 08:04 AM Lantern Pharma's LP-284 gets FDA orphan drug status for soft tissue sarcoma
Jan 20, 2026 08:00 AM Lantern Pharma's LP-284 Receives FDA Orphan Drug Designation for Soft Tissue Sarcomas
Jan 13, 2026 04:05 PM Form 4 Lantern Pharma Inc. For: Jan 09 Filed by: Chandru Vijay
Jan 13, 2026 04:05 PM Form 4 Lantern Pharma Inc. For: Jan 09 Filed by: Silberstein David S.
Jan 13, 2026 04:05 PM Form 4 Lantern Pharma Inc. For: Jan 09 Filed by: KEYSER D JEFFREY
Jan 13, 2026 04:05 PM Form 4 Lantern Pharma Inc. For: Jan 09 Filed by: Maccecchini Maria-Luisa
Jan 13, 2026 04:05 PM Form 4 Lantern Pharma Inc. For: Jan 09 Filed by: Schalop Lee Troy
View All Articles

Entities mentioned with LTRN

View All Entities